Dose titration of nebulized budesonide in young children

Pediatric Pulmonology

Volumn 23, Issue 4, 1997, Pages 270-277

  Vikre Jørgensen, Jennifer ^a,b   Agertoft, Lone ^a   Pedersen, Søren ^a  

^a KOLDING HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

aerosols; asthma; budesonide; nebulization; steroid; young children

Indexed keywords

BUDESONIDE; CORTICOSTEROID; PLACEBO; TERBUTALINE;

AEROSOL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; MALE; NEBULIZER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0030893278     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199704)23:4<270::AID-PPUL4>3.0.CO;2-Q     Document Type: Article

References (16)

1. Lenney W, Milner AD. At what age do bronchodilator drugs work? Arch Dis Child. 1978; 53:532-535.
2. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986; 2:1424-1425.
3. Prendiville A, Green S, Silverman M. Paradoxical response to salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax. 1987; 42:86-91.
4. Henry RL, Hiller EJ, Milner AD, Hodges IGC, Stokes GM. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child. 1984; 59:54-57.
5. Connolly N, Godfrey S. Assessment of the child with asthma. J Asthma Res. 1970; 8:31-36.
6. Tepper R, Sly P. Physiological outcomes. Eur Respir J. 1996; 9(suppl 21):125-155.
7. Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. Arch Dis Child. 1993; 68:356-359.
8. Lødrup Carlsen KC, Nikander K, Carlsen KH. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child. 1992; 67:1077-1079.
9. Gibson PG, Wong BJ, Hepperle MJ, Kline PA, Girgis-Gabardo A, Guyatt G, Dolovich J, Denburg JA, Ramsdale EH, Hargreave FE. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy. 1992; 22:525-532.
10. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children. A dose response study. Allergy Clin Immunol. 1995; 1:29-33.
11. Grimfeld A, Lesbros D, Ostinelli J, Caswell C. Long-term study of nebulised budesonide in young children with moderate to severe asthma. Eur Respir J. 1994; 7(suppl 18):27.
12. Wennergren G, Nordvall SL, Hedlin G, Møller C, Wille S, Åsbrink-Nilsson E. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Pædiatr. 1996; 85:183-189.
13. Dahlstrøm K, Larsson P. Lung deposition and systemic avaibility of budesonide inhaled as nebulised suspension from different nebulisers. J Aerosol Med. 1995; 8:79.
14. Everad ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch Dis Child. 1992; 67:580-585.
15. Nikander K. Drug delivery system. J Aerosol Med. 1994: 7(suppl 1):19-24.
16. Nordvall SL, Wennergren G, Åsbrink-Nilsson E. Nebulised budesonide suspension in infants and young children with asthma. Allergy Clin Immunol News. 1994; 6(suppl 2):433.